Constructive Bio appoints biopharma leader Jim Weissman to its Board of Directors
Constructive Bio, a leading synthetic biology company, today announces the appointment of Jim Weissman to its Board of Directors.
Engineering the future of biology with revolutionary genome synthesis and expanded genetic code technology.
QUICK LINKS
JOIN OUR NEWSLETTER
© 2026 Constructive Bio. All rights reserved.